insulin drugs glp 1 receptor agaonist market GLP-1 Agonist Size, Share GLP-1 Agonists Market Report 2025-2033,
Description
Trmper A, Trmper K, Trusheim H, Arnold R, Gke B, Hrsch D
A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity
N.RiviereG
ITT, Intention-to-treat
